#drug development

- HSRx Biopharmaceutical, a leading developer of polyfunctional-powered combination drugs for infectious ...

-606-patient MORE Study Sub-Group Analysis Examined Outcomes for Elderly (≥70 years) and Very Elderly (≥75 ...

- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)(TASE:TEVA) today announced that an updated investor presentation in ...

- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it has sent a letter to Robert J. ...

- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reiterated its commitment to its proposed ...

- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (TASE:TEVA) today announced that it has filed for premerger ...

- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a proposal to acquire all of the ...

- Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions ...

- Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions ...

-     CPhI is organising Pharma Project Management conference, on the best practice strategies to ...

- Transaction Designed to Enhance Shareholder Value By Unlocking Value of the Epigenetics Platform- TSX Exchange ...

- ReSearch Pharmaceutical Services Inc. ("RPS"), a leading global contract research organization (CRO), and Asklep Inc. ...

- GenScript and Open Monoclonal Technology, Inc. (OMT) today announced a joint road show with potential clients across ...

- ChanTest announced today the capability to perform a bioassay in conformance with current Good Manufacturing ...

- Telome Health, Inc. (THI), developer of the TeloTest(TM) diagnostic test that measures average telomere length, ...